首页> 外文OA文献 >237: The Role of Mid-Treatment 18F-FDG Pet in Assessing Early Functional Response and Predicting Outcomes in Patients with Locally Advanced Non-Small Cell Lung Cancer Undergoing Radical Chemoradiotherapy

【2h】

237: The Role of Mid-Treatment 18F-FDG Pet in Assessing Early Functional Response and Predicting Outcomes in Patients with Locally Advanced Non-Small Cell Lung Cancer Undergoing Radical Chemoradiotherapy

机译：237：中期治疗的18F-FDG宠物在接受自由基放化疗的局部晚期非小细胞肺癌患者评估早期功能反应和预测结果中的作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Baker Sarah; McEwan Ajb; Riauka Terence; Hudson Emmanuel; Chu Karen P.; Jan Hans-Sonke; Ghosh Sunita; Scrimger Rufus; Nijjar Tirath; Yee Don; Fairchild Alysa; Gabos Zsolt; Roa Wilson;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC). [J] . Decoster L, Schallier D, Everaert H, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2008,第1期

机译：诱导化疗后，通过18-氟脱氧葡萄糖正电子发射断层扫描（18FDG-PET）评估的完整代谢肿瘤反应预测局部晚期非小细胞肺癌（NSCLC）患者的预后良好。
2. 824 Role of gross tumour volume and dose parameters on outcome and toxicity of patients undergoing concurrent chemoradiotherapy for locally advanced non-small cell lung cancer [J] . L.De Petris, S.Friesland, I.Lax, European Journal of Cancer Supplements . 2003,第5期

机译：824总肿瘤体积和剂量参数对同时进行放化疗的局部晚期非小细胞肺癌患者预后和毒性的作用
3. 18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy. [J] . Edwin A Usmanij, Lioe-Fee de Geus-Oei, Esther G C Troost, The Journal of Nuclear Medicine . 2013,第9期

机译：联合放化疗治疗局部晚期非小细胞肺癌的18F-FDG PET早期反应评估。
4. Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients [C] . Wei Mu, Jin Qi, Hong Lu, SPIE Medical Imaging Conference . 2018

机译：PET / CT多模态融合图像的放射性标记生物标志物用于预测晚期非小细胞肺癌患者的免疫治疗反应
5. Modeling Dose-Function Response and Toxicity Pathways in Non-Small Cell Lung Cancer Patients Undergoing Radiation Treatment [D] . Owen, Daniel Rockwell. 2021

机译：非小细胞肺癌患者辐射治疗中的剂量函数响应和毒性途径
6. 18F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer [O] . Xiaohui Luan, Yong Huang, Song Gao, -1

机译：18F-αfatidePET / CT可以预测晚期非小细胞肺癌患者同时放化疗的近期疗效
7. Predicting Survival in Patients Undergoing Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Using Mid-Treatment Imaging Response and Radiation Parameters [O] . J. Zeng, H.M.T. Thomas, R. Rengan, 2020

机译：使用中等治疗成像响应和辐射参数预测局部晚期非小细胞肺癌（LA-NSCLC）患者的生存期

237: The Role of Mid-Treatment 18F-FDG Pet in Assessing Early Functional Response and Predicting Outcomes in Patients with Locally Advanced Non-Small Cell Lung Cancer Undergoing Radical Chemoradiotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅